Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Méthotrexate

Covered
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    Injectable Solution 25 mg/mL DIN : 2398427

Methotrexate Injectable

Covered
  • Active ingredient(s):
  • Manufactured by:
    Accord Healthcare Inc. (Accord)
  • Strength and dosage form:
    Injectable Solution 25 mg/mL DIN : 2464365

Methotrexate Sodium

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Injectable Solution 25 mg/mL DIN : 2182777

Methotrexate Sodium sans preservatif

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Injectable Solution 25 mg/mL DIN : 2182955

Metoject Subcutaneous

Covered
  • Active ingredient(s):
  • Manufactured by:
    Medexus Inc. (Medexus)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 22.5 mg/0.45 mL DIN : 2454777
    • Subcutaneous Injectable Solution syringe 10 mg/0,2 mL DIN : 2454831
    • Subcutaneous Injectable Solution syringe 25 mg/0.5 mL DIN : 2454874
    • Subcutaneous Injectable Solution syringe 12,5 mg/0,25 mL DIN : 2454750
    • Subcutaneous Injectable Solution syringe 15 mg/0,3 mL DIN : 2454858
    • Subcutaneous Injectable Solution syringe 17.5 mg/0.35 mL DIN : 2454769
    • Subcutaneous Injectable Solution syringe 20 mg/0.4 mL DIN : 2454866

pms-Methotrexate Injection

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 22.5 mg/0.45 mL DIN : 2539659
    • Subcutaneous Injectable Solution syringe 10 mg/0,2 mL DIN : 2539608
    • Subcutaneous Injectable Solution syringe 25 mg/0.5 mL DIN : 2539667
    • Subcutaneous Injectable Solution syringe 12,5 mg/0,25 mL DIN : 2539616
    • Subcutaneous Injectable Solution syringe 15 mg/0,3 mL DIN : 2539624
    • Subcutaneous Injectable Solution syringe 17.5 mg/0.35 mL DIN : 2539632
    • Subcutaneous Injectable Solution syringe 20 mg/0.4 mL DIN : 2539640

Methotrexate Subcutaneous

Covered
  • Active ingredient(s):
  • Manufactured by:
    Accord Healthcare Inc. (Accord)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 15 mg/0,3 mL DIN : 2491311
    • Subcutaneous Injectable Solution syringe 17.5 mg/0.35 mL DIN : 2491338
    • Subcutaneous Injectable Solution syringe 20 mg/0.4 mL DIN : 2491346
    • Subcutaneous Injectable Solution syringe 22.5 mg/0.45 mL DIN : 2491354
    • Subcutaneous Injectable Solution syringe 25 mg/0.5 mL DIN : 2491362

Methotrexate pour Injection BP

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    • Injectable Solution (syringe) 10 mg/0.4 ml DIN : 2422174
    • Injectable Solution (syringe) 15 mg/0.6 ml DIN : 2422182
    • Injectable Solution (syringe) 20 mg/0.8 ml DIN : 2422190
    • Injectable Solution (syringe) 25 mg/mL DIN : 2422204
    • Injectable Solution (syringe) 7.5 mg/0.3 mL DIN : 2422166

Methoprazine

Covered
  • Active ingredient(s):
  • Manufactured by:
    AA Pharma Inc. (AA Pharma)
  • Strength and dosage form:
    Tablet 2 mg DIN : 2238403

Nozinan

Covered
  • Active ingredient(s):
  • Manufactured by:
    Xediton Pharmaceuticals Inc. (Xediton)
  • Strength and dosage form:
    Injectable Solution 25 mg/mL DIN : 1927698

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.